FDA approves first cell-culture vaccine for seasonal influenza

Article

FDA approved Influenza Virus Vaccine (Flucelvax, Novartis Vaccines), the first cell-culture-derived vaccine, for individuals aged 18 years of age and older.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.